Literature DB >> 20080592

A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.

Kevin B Jones1, Virginia Piombo, Charles Searby, Gail Kurriger, Baoli Yang, Florian Grabellus, Peter J Roughley, Jose A Morcuende, Joseph A Buckwalter, Mario R Capecchi, Andrea Vortkamp, Val C Sheffield.   

Abstract

We report a mouse model of multiple osteochondromas (MO), an autosomal dominant disease in humans, also known as multiple hereditary exostoses (MHE or HME) and characterized by the formation of cartilage-capped osseous growths projecting from the metaphyses of endochondral bones. The pathogenesis of these osteochondromas has remained unclear. Mice heterozygous for Ext1 or Ext2, modeling the human genotypes that cause MO, occasionally develop solitary osteochondroma-like structures on ribs [Lin et al. (2000) Dev Biol 224(2):299-311; Stickens et al. (2005) Development 132(22):5055-5068]. Rather than model the germ-line genotype, we modeled the chimeric tissue genotype of somatic loss of heterozygosity (LOH), by conditionally inactivating Ext1 via head-to-head loxP sites and temporally controlled Cre-recombinase in chondrocytes. These mice faithfully recapitulate the human phenotype of multiple metaphyseal osteochondromas. We also confirm homozygous disruption of Ext1 in osteochondroma chondrocytes and their origin in proliferating physeal chondrocytes. These results explain prior modeling failures with the necessity for somatic LOH in a developmentally regulated cell type.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20080592      PMCID: PMC2836675          DOI: 10.1073/pnas.0910875107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice.

Authors:  D A Ovchinnikov; J M Deng; G Ogunrinu; R R Behringer
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

2.  The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate.

Authors:  C McCormick; G Duncan; K T Goutsos; F Tufaro
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 3.  A novel transgenic mouse model to study the osteoblast lineage in vivo.

Authors:  Christa Maes; Tatsuya Kobayashi; Henry M Kronenberg
Journal:  Ann N Y Acad Sci       Date:  2007-11       Impact factor: 5.691

4.  Recombination between inverted loxP sites is cytotoxic for proliferating cells and provides a simple tool for conditional cell ablation.

Authors:  Damien Grégoire; Marie Kmita
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-11       Impact factor: 11.205

5.  Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice.

Authors:  X Lin; G Wei; Z Shi; L Dryer; J D Esko; D E Wells; M M Matzuk
Journal:  Dev Biol       Date:  2000-08-15       Impact factor: 3.582

Review 6.  Engineering chromosomal rearrangements in mice.

Authors:  Y Yu; A Bradley
Journal:  Nat Rev Genet       Date:  2001-10       Impact factor: 53.242

7.  Two cell lineages, myf5 and myf5-independent, participate in mouse skeletal myogenesis.

Authors:  Malay Haldar; Goutam Karan; Petr Tvrdik; Mario R Capecchi
Journal:  Dev Cell       Date:  2008-03       Impact factor: 12.270

8.  Ucma--A novel secreted factor represents a highly specific marker for distal chondrocytes.

Authors:  Andreas Tagariello; Julia Luther; Melanie Streiter; Lydia Didt-Koziel; Manuela Wuelling; Cordula Surmann-Schmitt; Michael Stock; Nadia Adam; Andrea Vortkamp; Andreas Winterpacht
Journal:  Matrix Biol       Date:  2007-07-13       Impact factor: 11.583

Review 9.  Multiple osteochondromas.

Authors:  Judith V M G Bovée
Journal:  Orphanet J Rare Dis       Date:  2008-02-13       Impact factor: 4.123

10.  Regulation of zebrafish skeletogenesis by ext2/dackel and papst1/pinscher.

Authors:  Aurélie Clément; Malgorzata Wiweger; Sophia von der Hardt; Melissa A Rusch; Scott B Selleck; Chi-Bin Chien; Henry H Roehl
Journal:  PLoS Genet       Date:  2008-07-25       Impact factor: 5.917

View more
  54 in total

Review 1.  Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.

Authors:  Judith V M G Bovée; Pancras C W Hogendoorn; Jay S Wunder; Benjamin A Alman
Journal:  Nat Rev Cancer       Date:  2010-06-10       Impact factor: 60.716

2.  Epiphyseal abnormalities, trabecular bone loss and articular chondrocyte hypertrophy develop in the long bones of postnatal Ext1-deficient mice.

Authors:  Federica Sgariglia; Maria Elena Candela; Julianne Huegel; Olena Jacenko; Eiki Koyama; Yu Yamaguchi; Maurizio Pacifici; Motomi Enomoto-Iwamoto
Journal:  Bone       Date:  2013-08-17       Impact factor: 4.398

3.  Heparan sulfate antagonism alters bone morphogenetic protein signaling and receptor dynamics, suggesting a mechanism in hereditary multiple exostoses.

Authors:  Christina Mundy; Evan Yang; Hajime Takano; Paul C Billings; Maurizio Pacifici
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

4.  Cell cycle deregulation and mosaic loss of Ext1 drive peripheral chondrosarcomagenesis in the mouse and reveal an intrinsic cilia deficiency.

Authors:  Carlos E de Andrea; Ju-Fen Zhu; Huifeng Jin; Judith V M G Bovée; Kevin B Jones
Journal:  J Pathol       Date:  2015-03-03       Impact factor: 7.996

Review 5.  Genetic alterations in chondrosarcomas - keys to targeted therapies?

Authors:  Andre M Samuel; Jose Costa; Dieter M Lindskog
Journal:  Cell Oncol (Dordr)       Date:  2014-01-24       Impact factor: 6.730

6.  Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones.

Authors:  Beverly M Zak; Manuela Schuksz; Eiki Koyama; Christina Mundy; Dan E Wells; Yu Yamaguchi; Maurizio Pacifici; Jeffrey D Esko
Journal:  Bone       Date:  2011-02-15       Impact factor: 4.398

7.  EXTra hit for mouse osteochondroma.

Authors:  Judith V M G Bovée
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-02       Impact factor: 11.205

Review 8.  Glycobiology and the growth plate: current concepts in multiple hereditary exostoses.

Authors:  Kevin B Jones
Journal:  J Pediatr Orthop       Date:  2011 Jul-Aug       Impact factor: 2.324

Review 9.  Hereditary Multiple Exostoses: a review of clinical appearance and metabolic pattern.

Authors:  Giovanni Beltrami; Gabriele Ristori; Guido Scoccianti; Angela Tamburini; Rodolfo Capanna
Journal:  Clin Cases Miner Bone Metab       Date:  2016-10-05

10.  Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: a mechanism likely deranged in Hereditary Multiple Exostoses.

Authors:  Julianne Huegel; Christina Mundy; Federica Sgariglia; Patrik Nygren; Paul C Billings; Yu Yamaguchi; Eiki Koyama; Maurizio Pacifici
Journal:  Dev Biol       Date:  2013-03-01       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.